| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 2 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 3 | Exenatide | FAERS: 1 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 5 | Paclitaxel | FAERS: 1 | US FAERS | |
| 6 | Rasilez HCT | FAERS: 1 | US FAERS | |
| 7 | Rivastigmine | FAERS: 1 | US FAERS | |
| 8 | Sertraline | FAERS: 1 | US FAERS | |
| 9 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 10 | eltrombopag | FAERS: 1 | US FAERS | |
| 11 | paricalcitol | FAERS: 1 | US FAERS | |
| 12 | pimavanserin | FAERS: 1 | US FAERS | |
| 13 | Lenalidomide | SIDER | ||
| 14 | Lomustine | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.